NewGenIvf Group Limited (NIVFW)

USD 0.01

(-11.27%)

EBITDA Summary of NewGenIvf Group Limited

  • NewGenIvf Group Limited's latest annual EBITDA in 2023 was 384.3 Thousand USD , down -47.04% from previous year.
  • NewGenIvf Group Limited's latest quarterly EBITDA in 2023 FY was N/A , down -47.04% from previous quarter.
  • NewGenIvf Group Limited reported an annual EBITDA of 725.68 Thousand USD in 2022, up 23.62% from previous year.
  • NewGenIvf Group Limited reported an annual EBITDA of 587.01 Thousand USD in 2021, down 0.0% from previous year.
  • NewGenIvf Group Limited reported a quarterly EBITDA of N/A for 2022 FY, up 23.62% from previous quarter.
  • NewGenIvf Group Limited reported a quarterly EBITDA of N/A for 2021 FY, down 0.0% from previous quarter.

Annual EBITDA Chart of NewGenIvf Group Limited (2023 - 2021)

Historical Annual EBITDA of NewGenIvf Group Limited (2023 - 2021)

Year EBITDA EBITDA Growth
2023 384.3 Thousand USD -47.04%
2022 725.68 Thousand USD 23.62%
2021 587.01 Thousand USD 0.0%

Peer EBITDA Comparison of NewGenIvf Group Limited

Name EBITDA EBITDA Difference
Acadia Healthcare Company, Inc. 189.11 Million USD 99.797%
Addus HomeCare Corporation 106.55 Million USD 99.639%
AirSculpt Technologies, Inc. 28.31 Million USD 98.643%
Amedisys, Inc. 216.91 Million USD 99.823%
American Oncology Network, Inc. -39.35 Million USD 100.977%
Astrana Health, Inc. 123.68 Million USD 99.689%
Aveanna Healthcare Holdings Inc. 44.34 Million USD 99.133%
IMAC Holdings, Inc. -5.94 Million USD 106.462%
biote Corp. 9.23 Million USD 95.838%
Cryo-Cell International, Inc. -10.41 Million USD 103.689%
Cross Country Healthcare, Inc. 129.33 Million USD 99.703%
COMPASS Pathways plc -123.8 Million USD 100.31%
DocGo Inc. 32.72 Million USD 98.826%
The Ensign Group, Inc. 353.23 Million USD 99.891%
Healthcare Services Group, Inc. 75.21 Million USD 99.489%
InnovAge Holding Corp. 1.15 Million USD 66.698%
Assure Holdings Corp. -19.82 Million USD 101.939%
The Joint Corp. 9.14 Million USD 95.796%
LifeStance Health Group, Inc. -104.92 Million USD 100.366%
Mobile-health Network Solutions Class A Ordinary Shares -15.55 Million USD 102.471%
ModivCare Inc. -26.75 Million USD 101.437%
Novo Integrated Sciences, Inc. -5.84 Million USD 106.57%
Option Care Health, Inc. 376.79 Million USD 99.898%
P3 Health Partners Inc. -81.07 Million USD 100.474%
P3 Health Partners Inc. -81.07 Million USD 100.474%
The Pennant Group, Inc. 30.36 Million USD 98.735%
Surgery Partners, Inc. 446.1 Million USD 99.914%
Syra Health Corp. Class A Common Stock -2.83 Million USD 113.551%
Talkspace, Inc. -22.01 Million USD 101.746%
Talkspace, Inc. -22.01 Million USD 101.746%
The Oncology Institute, Inc. -70.45 Million USD 100.545%
The Oncology Institute, Inc. -70.45 Million USD 100.545%